Information about the metabolic effect of a given
cancer therapy allows you to adjust treatment strategies before physical
effects become apparent. But review of PET/CT datasets can be time-consuming
and cumbersome. Streamlining this process would let you make therapy adjustments
sooner and deliver care more specific to a patient’s disease development. PET
VCAR streamlines the assessment of metabolic data, giving you the ability to
interpret, quantify, and manage PET/CT datasets more efficiently.
Integrated into the OncoQuant oncology platform,
PET VCAR (Volume Computer Assisted Reading) improves visualization and
analytical monitoring of disease progression or response to therapy. It
provides the ability to compute various Standard Uptake Values (SUV), to measure
metabolic activity and volume for PET defined areas of activity, and compare
CT, PET/CT, and MR studies for baseline and follow-up studies.
- SUV PEAK generated by
- Summary Table for
interactive, efficient review of PET functional and CT morphological ROI/VOI
- Q.Check outputs
quantitative information for PET imaging and patient parameters for each loaded
- Adaptable workflow
for clinical reading to advanced research using tools supporting PERCIST,
EORTC, RECIST 1.0, 1.1, and WHO criteria (option).1
- Direct access to Integrated
1. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors. J Nucl Med. 2009; 50:122S - 150S.